DelMar Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
DMPI DelMar Pharmaceuticals Inc
FLR Fluor Corp
SPLK Splunk Inc
LB L Brands Inc
TEAM Atlassian Corporation PLC
GRAS Greenfield Farms Food Inc
CMS CMS Energy Corp
BAC Bank of America Corp
HPQ HP Inc
WNXDY Diebold Nixdorf AG
Go

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Based in CanadaCompany profile

DelMar Pharmaceuticals, Inc. is a clinical-stage drug development company. The Company focuses on the treatment of cancer. The Company is engaged in conducting clinical trials in the United States with its product candidate, VAL-083, as a treatment for glioblastoma multiforme (GBM), a form of brain cancer. VAL-083 is being evaluated in a Phase II clinical trial for the treatment of refractory GBM. In addition to its clinical development activities in the United States, the Company has obtained certain commercial rights to VAL-083 in China where it is approved as a chemotherapy for the treatment of chronic myelogenous leukemia (CML) and lung cancer. Its drug discovery research focuses on identifying validated clinical and commercial-stage compounds, and establishing a scientific rationale for development in orphan drug indications. VAL-083 is an alkylating agent, which crosses the blood-brain-barrier (BBB).

Price
Delayed
$2.47
Day's Change
-0.32 (-11.47%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.78
Day's Low
2.41
Volume
(Heavy Day)

Today's volume of 134,106 shares is on pace to be much greater than DMPI's 10-day average volume of 171,765 shares.

134,106

Microsoft surpasses Apple as most valuable U.S. company

5:51 pm ET November 30, 2018 (MarketWatch)
Print

By Wallace Witkowski, MarketWatch

After briefly surpassing Apple earlier in week, Microsoft retakes top spot for first time in 15 years

It's official: Microsoft Corp. on Friday took back its title as the most valuable U.S. company by market capitalization at the close of trading, unseating Apple Inc. after a more than two-year run in the top spot.

Microsoft (MSFT) shares rose 0.6% to close at $110.89 Friday for a market cap of $851.22 billion, while Apple's (AAPL) stock fell 0.5% to close at $178.58 for a market cap of $847.43 billion. Earlier in the week, Microsoft briefly snatched the crown away from Apple (http://www.marketwatch.com/story/microsoft-surpasses-apple-in-market-cap-for-first-time-in-more-than-8-years-2018-11-28) in intraday trading, but Apple had regained its top spot by the market close.

Since Aug. 1, 2013, Apple has held the title of most valuable U.S. company for all but two days when Alphabet Inc.'s (GOOGL) (GOOGL) market cap closed above Apple's on Feb. 2, 2016, and May 12, 2016, according to Dow Jones data.

Apple first surpassed Microsoft in market cap back on May 28, 2010, when both companies were worth about $226 billion, according to FactSet.

But back then, the largest U.S. company by market capitalization was Exxon Mobil Corp. (XOM), which Apple last unseated as most valuable in January 2012, after first taking it away in 2011 (http://www.marketwatch.com/story/apple-officially-takes-market-cap-crown-from-exxon-2011-08-10).

The last time Microsoft held the title as the most valuable U.S. company was Nov. 3, 2003, or 3,796 trading days, according to Dow Jones data.

Apple hit a market capitalization of $1.103 trillion back on Oct. 3, 2018, from which shares have fallen 23.5% in the meantime. But it's that decline that handed Microsoft the crown as Microsoft shares have only slipped 3.7% since then.

For the year, Microsoft shares are up 29.6% while Apple shares are up 5.5%. In comparison, the Dow Jones Industrial Average is up 3.3%, the S&P 500 index is up 3.2%, and the tech-heavy Nasdaq Composite Index is up 6.2%.

-Wallace Witkowski; 415-439-6400; AskNewswires@dowjones.com

(END) Dow Jones Newswires

November 30, 2018 17:51 ET (22:51 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.